Influenza A H1N1 M2 Antibody (14C2) - (A/WSN/1933) NB100-2073 from Novus Biologicals, a Bio-Techne Brand

Product Specs
ItemInfluenza A H1N1 M2 Antibody (14C2) - (A/WSN/1933)
CompanyNovus Biologicals, a Bio-Techne Brand
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberNB100-2073
ImmunogenM2 protein from A/WSN/33-infected CV1 cell lysate
Concentration1 mg/ml
ReactivityInfluenza A Virus H1N1
HostMouse
ApplicationsWestern Blot, Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunoprecipitation, Block/Neutralize
Conjugate/TagUnconjugated
IsotypeIgG1 Kappa
Clone14C2
Quantity100ug (also 0.025 mg)
FormatPBS with 1 mg/ml BSA
ClonalityMonoclonal
TargetInfluenza A H1N1 M2
Brand/TrademarkNovus Biologicals, a Bio-Techne Brand
PurityProtein A purified
Antibody TypePrimary Antibodies
StorageStore at -20C. Avoid freeze-thaw cycles

Available conjugates: Unconjugated

Specificity: Influenza A H1N1 M2 (A/WSN/1933)

United States: 10771 E Easter Ave

Centennial, Colorado 80112

United States

Phone:
303-730-1950
888-506-6887

Email: novus@novusbio.com

(1) The E3 ligase subunit FBXO45 binds the interferon-λ receptor and promotes its degradation during influenza virus infectionThe Journal of biological chemistryDecember 1, 2022Tsai M, Osman W, Adair J, ElMergawy R, Chafin L, Johns F, Farkas D, Elhance A, Londino J, Mallampalli RK.

(2) AXL receptor tyrosine kinase is required for T cell priming and antiviral immunityeLifeJune 28, 2016Schmid ET, Pang IK, Carrera Silva EA, Bosurgi L, Miner JJ, Diamond MS, Iwasaki A, Rothlin CV.

(3) Influenza virus M2 targets cystic fibrosis transmembrane conductance regulator for lysosomal degradation during viral infectionFASEB journal : official publication of the Federation of American Societies for Experimental BiologyJuly 1, 2015Londino JD, Lazrak A, Noah JW, Aggarwal S, Bali V, Woodworth BA, Bebok Z, Matalon S.

(4) Efficient influenza A virus replication in the respiratory tract requires signals from TLR7 and RIG-IProceedings of the National Academy of Sciences of the United States of AmericaAugust 20, 2013Pang IK, Pillai PS, Iwasaki A.

(5) Influenza matrix protein 2 alters CFTR expression and function through its ion channel activityAmerican journal of physiology. Lung cellular and molecular physiologyMay 1, 2013Londino JD, Lazrak A, Jurkuvenaite A, Collawn JF, Noah JW, Matalon S.

(6) Broader neutralizing antibodies against H5N1 viruses using prime-boost immunization of hyperglycosylated hemagglutinin DNA and virus-like particlesPloS oneJanuary 1, 2012Lin SC, Lin YF, Chong P, Wu SC.Abcam), anti-NA antibodies (ab70759; Abcam), anti-M1 antibodies (ab25918; Abcam), and anti-M2 antibodies (NB100–2073; Novus). Particles were also observed by transmission electron microscopy (TEM) as described previously

(8) Construction and characterization of insect cell-derived influenza VLP: cell binding, fusion, and EGFP incorporationJournal of biomedicine & biotechnologyJanuary 1, 2010Pan YS, Wei HJ, Chang CC, Lin CH, Wei TS, Wu SC, Chang DK.

Influenza A H1N1 M2 Antibody (14C2) - (A/WSN/1933)